Sexually Transmitted Diseases (STDs) are diseases that spread from person-to-person through sexual contact. Early identification or diagnosis of STDs can help stop further transmission. Laboratory tests can identify the cause and detect co-infections through blood tests, urine samples, swab tests, lumbar puncture, and fluids samples. Testing for a disease in someone who doesn't have symptoms is called screening. The screening can be done for a variety of infections like HIV, hepatitis B, chlamydia, syphilis, gonorrhea, and hepatitis C. Cervical cancer is often caused by certain strains of HPV. Treatment of STDs can be done by antibiotics and antiviral drugs which prevents the further spread of disease.
Market Dynamics
The increasing prevalence of STDs, government fundings for the treatment and management of STDs is expected to drive the global diagnostic testing of STDs market growth. For instance, on February 2, 2023, Mylab Discovery Solutions Pvt. Ltd., an India-based biotechnology company, launched rapid test kits for sexually transmitted diseases including human immunodeficiency virus (HIV), Hepatitis C virus (HCV), and syphilis. Among these tests, HIV 1/2 Ab, and HCV Ab are rapid tests for the detection of antibodies specific to HIV-1, HIV-2, and HCV respectively, while the syphilis antibody test detects antibodies (IgG, IgA, and IgM) to aid in the diagnosis of syphilis.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook